Toni Choueiri, MD· @DrChoueiri · X·· 2 days agoScore70
Body
Excellent overview by @NivenMehra of emerging immune therapies in #ProstateCancer at #ESMO26!
• Promising early signals with KLK2×CD3 & masked PSMA×CD3 T-cell engagers
• Personalized neoantigen vaccines gaining traction
• CAR-T remains proof-of-concept
@myESMO @oncoalert
1056 views · 11 likes · 12 reposts · 0 replies
Source: Toni Choueiri, MD · x.com